使用蛋白质组积溶性改变方法探索心脏甘地的抗癌机制
Wenjie Qin1, Yinhua Deng1, Huan Ren1
1Department of Pharmacy, The First Affiliated Hospital of Hunan Normal University (Hunan Provincial People's Hospital), Changsha, China.
Cancer medicine
|October 1, 2024
概括
心脏糖化物通过改变蛋白质溶解度和影响癌细胞代谢,显示出作为癌症药物的潜力. 需要进一步的研究来探索它们的临床应用.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 已知用于治疗心力衰竭的心脏糖化物 (CGs) 具有抗癌性质.
- 了解CG在癌症中的机制对于治疗开发至关重要.
研究的目的:
- 使用蛋白质组合溶解性改变 (PISA) 研究CG的抗癌机制.
- 识别癌细胞中与CG相互作用的关键蛋白质,重点关注新陈代谢和线粒体功能.
主要方法:
- 基于酸盐和完整细胞的PISA测定在CG治疗的癌细胞上进行.
- 质谱和生物信息学确定了差异溶解蛋白 (DSPs).
- 分子对接和对公众基因表达数据的重新分析验证了相互作用和效应.
主要成果:
- 基因组显示出广泛的相互作用,影响PKM2,ANXA2,SLC16A1,GOT2和GLUD1.1等蛋白质.
- 分子对接证实了稳定的CG蛋白相互作用.
- 已经证明CG会影响癌症代谢和细胞信号通路.
结论:
- 通过调节细胞过程,CG可以重新用于癌症治疗.
- PISA数据揭示了CG的多药效应.
- 需要进一步的研究来探索CG的机制和癌症中的临床潜力.
关键词:
在 PISA 测试中,心脏的葡萄糖化物.数字毒素是一种数字毒素.消毒素 (Digoxin) 是一种消毒剂.药物重新定位 药物重新定位药物重用是为了改变药物的用途.偏离目标 - 偏离目标.乌阿巴林,就是这样.更多相关视频
13:21Chemically-blocked Antibody Microarray for Multiplexed High-throughput Profiling of Specific Protein Glycosylation in Complex Samples
Published on: May 4, 2012
15.7K
08:03Hybrid Cell Analysis System to Assess Structural and Contractile Changes of Human iPSC-Derived Cardiomyocytes for Preclinical Cardiac Risk Evaluation
Published on: October 20, 2022
1.7K
相关概念视频
01:26Heart Failure Drugs: Inotropic Agents
535
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
535
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K